NCT01734902View on ClinicalTrials.gov

Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2012

Primary Completion Date

December 1, 2012

Study Completion Date

December 1, 2012

Conditions
Healthy
Interventions
DRUG

Hyoscine butylbromide

sugar coated tablets for oral administration

DRUG

Hyoscine butylbromide

drops for oral administration

Trial Locations (1)

Unknown

202.846.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01734902 - Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter